Medicinal – Page 29

Research Topic: Medicinal

Ayahuasca enhances the formation of hippocampal-dependent episodic memory without impacting false memory susceptibility in experienced ayahuasca users: An observational study

mycolabadmin

Researchers studied how ayahuasca affects memory in experienced Santo Daime church members who use it regularly. Surprisingly, instead of impairing memory like other psychedelics typically do, ayahuasca enhanced people’s ability to remember details of events they witnessed. Importantly, the drug did not make people more susceptible to false memories or memory distortions, even though the entire study occurred while participants were under its acute effects.

Antidepressant Switching as a Proxy Phenotype for Drug Nonresponse: Investigating Clinical, Demographic, and Genetic Characteristics

mycolabadmin

This study examined why some people don’t respond well to common antidepressant medications called SSRIs. Researchers used prescription records from over 38,000 people to identify those who switched to different antidepressants as a sign of poor response. They found that people with higher education and income were less likely to switch medications, and that genetic factors influenced who responded poorly to treatment. The research demonstrates that switching medications can serve as a reliable marker for identifying nonresponders, potentially helping doctors personalize antidepressant prescribing in the future.

Medicinal Mushrooms: Their Bioactive Components, Nutritional Value and Application in Functional Food Production—A Review

mycolabadmin

Medicinal mushrooms like Reishi, Lion’s Mane, and Shiitake contain powerful compounds that may help fight cancer, boost immunity, and reduce inflammation. These mushrooms are low in calories and can be added to everyday foods like bread, pasta, and meat products to boost their nutritional value. While promising, more research is needed to confirm how much people should consume and whether they interact safely with medications.

Biological Characteristics, Domesticated Cultivation Protocol, Antioxidant Activity, and Protective Effects against Cellular Oxidative Stress of an Underutilized Medicinal Mushroom: Fomitopsis palustris

mycolabadmin

Researchers successfully grew and studied Fomitopsis palustris, a medicinal mushroom, in laboratory conditions. They discovered that the mushroom contains beneficial compounds that protect cells from damage caused by harmful free radicals. The polysaccharides extracted from the mushroom boosted the cells’ natural defense systems and reduced oxidative stress markers, suggesting potential health benefits for treating age-related and degenerative diseases.

The influence of intercropping Paris polyphylla with Polygonatum cyrtonema or Ganoderma lucidum on rhizosphere soil microbial community structure and quality of Paris polyphylla

mycolabadmin

Researchers studied how planting Paris polyphylla (a rare medicinal plant) together with other plants affects soil health and medicine quality. Growing P. polyphylla alone caused problems like soil nutrient depletion and harmful microorganism growth. When grown alongside Ganoderma lucidum mushrooms or Polygonatum cyrtonema plants, the soil became healthier with better nutrients and beneficial microorganisms. This resulted in higher yields and better quality medicinal compounds in the P. polyphylla.

Comparative transcriptomic insights into the domestication of Pleurotus abieticola for coniferous cultivation

mycolabadmin

Researchers studied a special mushroom called Pleurotus abieticola that can grow on coniferous trees like spruce and larch. Usually, mushrooms prefer broadleaf trees, but this species can thrive on conifer wood, which makes up 70% of Chinese forests. By analyzing the mushroom’s genes and growth conditions, scientists found the best ways to cultivate it and discovered it’s rich in protein and beneficial compounds. This breakthrough could help create sustainable mushroom farming using forest resources that were previously underutilized.

Ethical Considerations Regarding Psychedelics for Clinical Pain Research

mycolabadmin

This paper examines the ethical considerations necessary when conducting research on psychedelics like psilocybin for treating chronic pain. With chronic pain affecting millions of Americans and traditional treatments like opioids causing significant problems, researchers are exploring psychedelics as alternatives. The authors provide guidance on obtaining proper informed consent, protecting vulnerable patients, managing regulatory requirements, and ensuring research benefits participants while following four key ethical principles: autonomy, beneficence, justice, and avoiding harm.

Light-responsive transcription factor CmOzf integrates conidiation, fruiting body development, and secondary metabolism in Cordyceps militaris

mycolabadmin

Scientists studied a medicinal fungus called Cordyceps militaris and discovered that a protein called CmOzf acts as a master controller of several important processes. When light shines on the fungus, it activates CmOzf, which helps the fungus produce spores for reproduction through a specific genetic pathway. Interestingly, when CmOzf is blocked, the fungus produces fewer spores but makes more pigments and beneficial compounds. This discovery could help improve the production of medicinal compounds from this fungus and its use as a natural pest control agent.

Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders

mycolabadmin

This comprehensive review explores how psychedelic drugs like psilocybin mushrooms, DMT, and LSD may offer new hope for treating depression, anxiety, and PTSD, especially for patients who don’t respond to conventional antidepressants. Historically used in spiritual ceremonies for thousands of years, these compounds are now being scientifically studied and show promise with fewer side effects than many traditional psychiatric medications. The authors emphasize that while results are encouraging, more research and regulatory approval are needed before these treatments become widely available in mainstream medicine.

Evaluation of Bioactive Compounds, Antioxidant Activity, and Anticancer Potential of Wild Ganoderma lucidum Extracts from High-Altitude Regions of Nepal

mycolabadmin

Researchers studied a medicinal mushroom called Ganoderma lucidum (Reishi) collected from high mountains in Nepal to understand its health benefits. They tested different ways to extract beneficial compounds from the mushroom and found that using ethanol was most effective. The extracts showed strong cancer-fighting properties against cervical cancer cells and powerful antioxidant effects that may help protect the body from damage. These findings suggest this Himalayan mushroom has real therapeutic potential for treating cancer and other diseases.